Endo International | Betriebsaufwand



Operating Expenses Veränderung Datum
AbbVie USD 9.61B 6.98B 2025-03
Amarin USD 58.77M 56.06M 2025-03
ANI Pharmaceuticals USD 170.93M 24.02M 2025-03
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
Eli Lilly USD 7.32B 1.06B 2025-03
Hikma Pharmaceutical USD 1.31B 63M 2024-12
Ligand Pharmaceuticals USD 81.55M 29.1M 2025-03
Merck USD 9.66B 1.67B 2025-03
Novartis USD 11.28B 1.73B 2024-12
Pacira USD 166.93M 4.38M 2025-03
Perrigo USD 964.5M 61.1M 2025-03
Pfizer USD 10.05B 8.12B 2025-03
Supernus Pharmaceuticals USD 152.75M 17.91M 2024-12
Takeda JPY 1.13T 51.15B 2025-03
Teva Pharmaceutical Industries USD 3.37B 402M 2025-03
Xeris Pharmaceuticals USD 58.42M 8.74M 2024-12
Zoetis USD 1.41B 175M 2025-03


Endo International Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.